Robert G. Maki, MD, PhD

Abramson Cancer Center
Philadelphia, Pennsylvania, United States

Presentation(s):

• Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB

  Friday, November 18, 2022
  10:30 AM – 10:38 AM